STOCK TITAN

Smith & Nephew to redeem $350M 5.15% notes

Smith & Nephew will fully redeem its $350 million 5.150% notes due 2027 on October 5, 2026, ending interest accrual and cancelling the NYSE listing for the notes.

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

SMITH & NEPHEW PLC (SNN) is redeeming in full its $350,000,000 5.150% Notes due 2027. The company has issued a notice of redemption for the entire outstanding principal amount of these Securities under the October 14, 2020 Indenture.

The notes will be redeemed on October 5, 2026, at a redemption price calculated in accordance with the Indenture, and their New York Stock Exchange listing will be cancelled on or shortly after that date. On the Redemption Date, the redemption price will become due and payable, interest will cease to accrue, and the notes will no longer be outstanding. Before that date, Smith & Nephew will irrevocably deposit with the Trustee or a Paying Agent funds sufficient to pay the total redemption price, after which holders’ rights will be limited to receiving the redemption amount, unpaid interest and any additional amounts due.

Positive

  • $350,000,000 of 5.150% notes due 2027 will be fully redeemed, reducing this outstanding debt and associated interest costs.
  • Redemption on October 5, 2026 will stop interest accrual on the notes, lowering future cash interest outflows on this instrument.

Negative

  • None.
Principal amount of notes $350,000,000 Total outstanding principal of 5.150% Notes due 2027 to be redeemed
Coupon rate 5.150% Interest rate on the Notes due 2027 being redeemed
Maturity year of notes 2027 Original maturity of the 5.150% Notes now called for redemption
Redemption Date October 5, 2026 Date on which the notes will be redeemed and interest will cease to accrue
Indenture date October 14, 2020 Date of the Indenture governing the 5.150% Notes due 2027
Exchange listing status Cancelled on or shortly after October 5, 2026 Planned NYSE delisting of the 5.150% Notes due 2027
Indenture financial
"pursuant to the terms of the Indenture dated October 14, 2020"
An indenture is a legal agreement between a company that borrows money by issuing bonds and the people who buy those bonds. It explains the rules the company must follow, like paying back the money and keeping certain financial promises. This document helps both sides understand their rights and responsibilities.
Redemption Date financial
"The outstanding Securities will be redeemed on October 5, 2026 (the "Redemption Date")"
The redemption date is the specific day when a debt-like security (such as a bond, preferred share, or certificate) must be repaid by the issuer and the investor receives the principal plus any final interest or dividends. It matters to investors because it tells when cash will return, shapes the effective return and price of the security, and creates reinvestment and timing considerations—like knowing when a loan is due so you can plan what to do with the returned money.
Redemption Price financial
"at the redemption price to be calculated in accordance with the terms of the Indenture (the "Redemption Price")"
The redemption price is the amount of money a person receives when they sell or redeem a bond or investment before it matures. It’s important because it determines how much you get back and can affect your overall profit or loss on the investment. Think of it like the price you get when returning a gift card early—it's the value you receive at that time.
foreign private issuer regulatory
"Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
forward-looking statements regulatory
"This announcement contains certain "forward-looking" statements within the meaning of Section 27A"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did SMITH & NEPHEW PLC (SNN) announce about its 5.150% Notes due 2027?

Smith & Nephew announced it has issued a notice to redeem in full its $350,000,000 5.150% Notes due 2027. The entire outstanding principal amount of these Securities will be repaid in accordance with the terms of the October 14, 2020 Indenture.

When will Smith & Nephew (SNN) redeem its $350 million 5.150% notes?

The outstanding $350,000,000 5.150% Notes due 2027 will be redeemed on October 5, 2026, the stated Redemption Date. On that date, the redemption price will become due and payable and interest on the Securities will cease to accrue.

What happens to the NYSE listing of Smith & Nephew’s 5.150% notes (SNN)?

The company states that the listing of the 5.150% Notes due 2027 on the New York Stock Exchange will be cancelled on, or shortly after, October 5, 2026, in connection with the full redemption of these Securities.

How will Smith & Nephew (SNN) fund the redemption of its 5.150% notes?

Smith & Nephew states that before the Redemption Date it will irrevocably deposit with the Trustee or a Paying Agent an amount of money sufficient to pay the total Redemption Price for each of the Securities, as calculated under the Indenture.

What rights do holders of Smith & Nephew’s 5.150% notes (SNN) have after funds are deposited?

Once the company deposits sufficient funds with the Trustee or a Paying Agent, all rights of holders will cease except their rights to receive the Redemption Price, unpaid interest and any additional amounts due on the Redemption Date, and the Securities will no longer be outstanding.

Who can investors contact at Smith & Nephew (SNN) about the note redemption?

For information about the redemption of the Securities, Smith & Nephew directs inquiries to Group Treasury, specifically Group Treasurer Adam Richford, via telephone at +44 01923 477 100.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
 
 
 
 
Form 6-K
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the
Securities Exchange Act of 1934
 
September 18, 2026
 
Commission File Number 001-14978
 
SMITH & NEPHEW plc
(Registrant’s name)
 
Building 5, Croxley Park, Hatters Lane
Watford, England, WD18 8YE
 (Address of principal executive office)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F           Form 40-F __
 
 
 
 
 
 
Redemption of $350,000,000 5.150% Notes due 2027
 
Smith & Nephew plc
 
 
            $350,000,000 5.150% Notes due 2027 (CUSIP: 83192PAC2, ISIN: US83192PAC23) (the "Securities") 
 
 
September 18, 2026. Smith & Nephew plc (the "Issuer") announces that it has issued a notice of redemption for the entire outstanding principal amount of the Securities. A notice of redemption pursuant to the terms of the Indenture dated October 14, 2020 governing the Securities has been distributed to The Bank of New York Mellon, London Branch, as Trustee (the "Trustee").
 
The outstanding Securities will be redeemed on October 5, 2026 (the "Redemption Date") at the redemption price to be calculated in accordance with the terms of the Indenture (the "Redemption Price"). Accordingly, the listing of the Securities on the New York Stock Exchange will be cancelled on, or shortly after, October 5, 2026.
 
The location where Holders may surrender the Securities and obtain payment of the Redemption Price is The Bank of New York Mellon, London Branch, 160 Queen Victoria Street, London EC4V 4LA, United Kingdom, Attn: Corporate Trust Administration.
 
On the Redemption Date, the Redemption Price will become due and payable and interest on the Securities will cease to accrue. Before the Redemption Date, the Issuer will irrevocably deposit with the Trustee or with a Paying Agent an amount of money sufficient to pay the total Redemption Price of each of the Securities. When the Issuer makes such a deposit, all rights of holders of the Securities will cease, except the holders' rights to receive the Redemption Price, and unpaid interest and any additional amounts due on the Redemption Date, and the Securities will no longer be outstanding.
 
For further information in relation to the redemption of the Securities, please contact:
 
Group Treasury:
Adam Richford
Group Treasurer
Telephone: +44 01923 477 100
 
 
 
Smith+Nephew Forward-looking Statements
 
This announcement contains certain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. For example, statements regarding expected revenue growth and trading profit margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: conflicts in Europe and the Middle East, economic and financial conditions in the markets we serve, especially those affecting healthcare providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal and financial compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and disposals, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organization to adapt to market developments; relationships with healthcare professionals; reliance on information technology and cybersecurity; disruptions due to natural disasters, weather and climate change related events; changes in customer and other stakeholder sustainability expectations; changes in taxation regulations; effects of foreign exchange volatility; effects of AI use and deployment; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew's most recent annual report on Form 20-F for the year ended December 31, 2025 and interim financial statements on Form 6-K for the six months period ended June 27, 2026, which are available on the SEC's website at www. sec.gov and the Offer to Purchase, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith+Nephew as of the date of the statement. The Company can give no assurance that any goal or plan set forth in the Company's forward-looking statements will be achieved and readers are cautioned not to place undue reliance on such statements, which speak only as of the date made. All written or oral forward-looking statements attributable to Smith+Nephew are qualified by this caution. Smith+Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith+Nephew's expectations.
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
 
 
 
Smith & Nephew plc
 
 
(Registrant)
 
 
 
 
 
 
Date: September 18, 2026
By:
/s/ Helen Barraclough
 
 
Helen Barraclough
 
 
Company Secretary

Keep reading